Retinal blood flow in response to an intravitreal injection of ranibizumab for neovascular age-related macular degeneration

Acta Ophthalmologica

Volumn 90, Issue 1, 2012, Pages

  Micieli, Jonathan A ^a   Tsui, Edmund ^a   Lam, Wai Ching ^a   Brent, Michael H ^a   Devenyi, Robert G ^a   Hudson, Chris ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

age related macular degeneration; blood flow; intravitreal; ranibizumab; vascular endothelial growth factor

Indexed keywords

PEGAPTANIB; RANIBIZUMAB;

ADULT; ARTERIOLE; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HEMODYNAMICS; HUMAN; LASER FLOWMETER; NEOVASCULAR AGE RELATED MACULAR DEGENERATION; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT RESPONSE; VENULE; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; LASER-DOPPLER FLOWMETRY; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84856551676     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02209.x     Document Type: Article

References (34)

1. Battaglia Parodi M, Iacono P, Cascavilla ML, Zucchiatti I, Kontadakis DS, Vergallo S, &, Bandello F, (2010): Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema. Eur J Ophthalmol 20: 1076-1078.
2. Bergers G, Song S, Meyer-Morse N, Bergsland E, &, Hanahan D, (2003): Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111: 1287-1295. (Pubitemid 36554699)
3. Bonnin P, Pournaras JA, Lazrak Z, Cohen SY, Legargasson JF, Gaudric A, Levy BI, &, Massin P, (2010): Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin) in neovascular age-related macular degeneration. Acta Ophthalmol 88: 641-645.
4. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, &, Schneider S, (2006): Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: 1432-1444. (Pubitemid 44511558)
5. Chen Y, Medhora M, Falck JR, Pritchard KA Jr, &, Jacobs ER, (2006): Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 291: L378-L385. (Pubitemid 44343713)
6. De Mey JG, &, Vanhoutte PM, (1982): Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res 51: 439-447. (Pubitemid 12034483)
7. Delori FC, Fitch KA, Feke GT, Deupree DM, &, Weiter JJ, (1988): Evaluation of micrometric and microdensitometric methods for measuring the width of retinal vessel images on fundus photographs. Graefes Arch Clin Exp Ophthalmol 226: 393-399.
8. Feke GT, Goger DG, Tagawa H, &, Delori FC, (1987): Laser Doppler technique for absolute measurement of blood speed in retinal vessels. IEEE Trans Biomed Eng 34: 673-680.
9. Fukaya Y, &, Ohhashi T, (1996): Acetylcholine- and flow-induced production and release of nitric oxide in arterial and venous endothelial cells. Am J Physiol 270: H99-H106.
10. Garcia JP Jr, Garcia PT, &, Rosen RB, (2002): Retinal blood flow in the normal human eye using the canon laser blood flowmeter. Ophthalmic Res 34: 295-299. (Pubitemid 36151331)
11. Gilmore ED, Hudson C, Nrusimhadevara RK, Harvey PT, Mandelcorn M, Lam WC, &, Devenyi RG, (2007): Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation in early sight-threatening diabetic retinopathy. Invest Ophthalmol Vis Sci 48: 1744-1750. (Pubitemid 351261361)
12. Gilmore ED, Hudson C, Nrusimhadevara RK, Ridout R, Harvey PT, Mandelcorn M, Lam WC, &, Devenyi RG, (2008): Retinal arteriolar hemodynamic response to a combined isocapnic hyperoxia and glucose provocation in early sight-threatening diabetic retinopathy. Invest Ophthalmol Vis Sci 49: 699-705.
13. von Hanno T, Kinge B, &, Fossen K, (2010): Retinal artery occlusion following intravitreal anti-VEGF therapy. Acta Ophthalmol 88: 263-266.
14. Ikram MK, van Leeuwen R, Vingerling JR, Hofman A, &, de Jong PT, (2005): Retinal vessel diameters and the risk of incident age-related macular disease: the Rotterdam Study. Ophthalmology 112: 548-552. (Pubitemid 41108851)
15. Jeganathan VSE, Kawasaki R, Wang JJ, Aung T, Mitchell P, Saw SM, &, Wong TY, (2008): Retinal vascular valiber and age-related macular degeneration: the Singapore Malay Eye Study. Am J Ophthalmol 146: 954-959.
16. Jo N, Mailhos C, Ju M, et al., (2006): Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168: 2036-2053. (Pubitemid 43825322)
17. Kida T, Harino S, Sugiyama T, Kitanishi K, Iwahashi Y, &, Ikeda T, (2002): Change in retinal arterial blood flow in the contralateral eye of retinal vein occlusion during glucose tolerance test. Graefes Arch Clin Exp Ophthalmol 240: 342-347. (Pubitemid 36075607)
18. Kisilevsky M, Hudson C, Mardimae A, Wong T, &, Fisher J, (2008a): Concentration-dependent vasoconstrictive effect of hyperoxia on hypercarbia-dilated retinal arterioles. Microvasc Res 75: 263-268. (Pubitemid 351240938)
19. Kisilevsky M, Mardimae A, Slessarev M, Han J, Fisher J, &, Hudson C, (2008b): Retinal arteriolar and middle cerebral artery responses to combined hypercarbic/hyperoxic stimuli. Invest Ophthalmol Vis Sci 49: 5503-5509.
20. Klein R, Klein BE, Tomany SC, &, Wong TY, (2004): The relation of retinal microvascular characteristics to age-related eye disease: the Beaver Dam eye study. Am J Ophthalmol 137: 435-444. (Pubitemid 38328633)
21. Liew G, Kaushik S, Rochtchina E, Tan AG, Mitchell P, &, Wang JJ, (2006): Retinal vessel signs and 10-year incident age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 113: 1481-1487. (Pubitemid 44292308)
22. Mendrinos E, Mangioris G, Papadopoulou D, Donati G, &, Pournaras C, (2009): One year results of the effect of intravitreal ranibizumab on the retinal arteriolar diameter in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (in press).
23. Mete A, Saygili O, Bayram M, &, Bekir N, (2010): Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration. J Clin Ultrasound 38: 66-70.
24. Micieli JA, Micieli A, &, Smith AF, (2010): Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database. Can J Ophthalmol 45: 231-238.
25. Milbocker MT, Feke GT, &, Goger DG, (1991): Laser Doppler velocimetry stabilized in one dimension. IEEE Trans Biomed Eng 38: 928-930.
26. Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, &, Pournaras CJ, (2009): Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration. Ophthalmology 116: 1755-1761.
27. Pournaras CJ, Rungger-Brandle E, Riva CE, Hardarson SH, &, Stefansson E, (2008): Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 27: 284-330.
28. Rose PA, &, Hudson C, (2007): Comparison of retinal arteriolar and venular variability in healthy subjects. Microvasc Res 73: 35-38. (Pubitemid 46072899)
29. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, &, Kim RY, (2006): Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419-1431. (Pubitemid 44511557)
30. Soliman W, Vinten M, Sander B, Soliman KA, Yehya S, Rahman MS, &, Larsen M, (2008): Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema. Acta Ophthalmol 86: 365-371.
31. Tayyari F, Venkataraman ST, Gilmore ED, Wong T, Fisher J, &, Hudson C, (2009): The relationship between retinal vascular reactivity and arteriolar diameter in response to metabolic provocation. Invest Ophthalmol Vis Sci 50: 4814-4821.
32. Venkataraman ST, Hudson C, Fisher JA, Rodrigues L, Mardimae A, &, Flanagan JG, (2008): Retinal arteriolar and capillary vascular reactivity in response to isoxic hypercapnia. Exp Eye Res 87: 535-542.
33. Xu L, Want S, Li Y, &, Jonas JN, (2006): Retinal vascular abnormalities and prevalence of age-related macular degeneration in adult Chinese: the Beijing Eye Study. Am J Ophthalmol 142: 688-689. (Pubitemid 44442066)
34. Yoshida A, Feke GT, Mori F, Nagaoka T, Fujio N, Ogasawara H, Konno S, &, McMeel JW, (2003): Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am J Ophthalmol 135: 356-361. (Pubitemid 36279523)